Friday, July 9, 2021

GSK, Vir Biotech seek emergency use authorisation for COVID-19 antibody

GlaxoSmithKline (GSK) and Vir Biotechnology have submitted a request to the US Food and Drug Administration (FDA), seeking an emergency use authorisation (EUA) for their COVID-19 antibody VIR-7831.

The EUA application is seeking authorisation for VIR-7831, an investigational dual-action monoclonal antibody (mAb), for the treatment of adults and adolescents with mild-to-moderate COVID-19 who are at risk of progression to hospitalisation or death.

The submission is based on an interim analysis of efficacy and safety data from the Phase III COMET-ICE trial, which demonstrated an 85% reduction in hospitalisation or death in patients receiving VIR-7831 compared to placebo.

Following this positive result, the independent data monitoring committee recommended that the trial be stopped for enrolment, due to evidence of ‘profound efficacy’.

GSK and Vir Biotech added that data from the COMET-ICE trial will also form the basis of a biologics license application (BLA) submission to the FDA.

The companies are also continuing discussions with the European Medicines Agency (EMA) and other global regulators for the potential approval of VIR-7831 to treat patients with COVID-19.

Source link

Stay Connected


Latest Articles

Covid’s second wave proves lethal for pregnant women

At SVP Hospital in Ahmedabad – one of the major Covid-19 hospitals of the city – 148 pregnant women with Covid-19 infection were admitted...

7 Tips to Keep Your Gut Healthy

This is common to say health (and illness) starts in your gut. If you have poor gut health, you’ll experience anything from wrinkled skin, to...

SII making first batch of Covovax: Poonawalla

The first batch of Covovax, a Covid-19 vaccine developed by Novavax Inc, is being manufactured at the Serum Institute of India's Pune facility, SII...

Sputnik V is safest among all Covid-19 vaccines, no deaths recorded: Buenos Aires study

A study by the Buenos Aires Ministry of Health to monitor the safety of the Sputnik V vaccine against Covid-19 confirmed on Thursday that...

Telangana caps Covid treatment charges in private hospitals

Hyderabad: The government of Telangana on Wednesday issued orders fixing treatment and investigation charges for Covid-19 in private hospitals.The state government, which had capped...